Related Experiment Videos
Selected ultratrace elements in total parenteral nutrition solutions
Y N Berner1, T R Shuler, F H Nielsen
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
The American Journal of Clinical Nutrition
|November 1, 1989
Summary
Total parenteral nutrition (TPN) solutions often contain widespread ultratrace element contamination. Intakes of molybdenum, nickel, vanadium, and cadmium from TPN were comparable to dietary absorption, highlighting potential health risks.
Area of Science:
- Clinical Nutrition
- Trace Element Metabolism
- Parenteral Nutrition
Background:
- Ultratrace elements can be essential or toxic to human health.
- Long-term total parenteral nutrition (TPN) patients risk significant ultratrace element exposure via TPN solutions.
- Contaminants in TPN solutions pose an underappreciated risk for patients receiving long-term nutritional support.
Purpose of the Study:
- To quantify the intake of selected ultratrace elements from standard TPN solutions.
- To compare TPN-derived ultratrace element intake with absorption from dietary sources in healthy individuals.
- To assess the potential health implications of ultratrace element contamination in TPN.
Main Methods:
- Analysis of a standard TPN solution to determine ultratrace element concentrations.
- Calculation of daily ultratrace element intake for TPN patients based on solution analysis.
- Comparison of TPN-derived intake with established values for gastrointestinal absorption from food.
Main Results:
- Widespread and variable contamination of TPN solutions with multiple ultratrace elements was observed.
- Daily intakes of molybdenum (Mo), nickel (Ni), vanadium (V), and cadmium (Cd) from TPN contamination were comparable to normal dietary absorption.
- Aluminum (Al) intake from TPN was notably high, while boron (B) intake was low (approx. 10% of normal absorption).
Conclusions:
- Standard TPN solutions are a significant source of unintended ultratrace element exposure.
- The biological impact of intravenously administered ultratrace elements requires further investigation.
- Particular attention is needed for patients on home TPN regarding potential ultratrace element toxicity.